Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody

Prostate-specific membrane antigen (PSMA) is expressed at high levels on malignant prostate cells and is likely an important therapeutic target for the treatment of prostate carcinoma. Current immunotherapy approaches to target PSMA include peptide, cell, vector or DNA-based vaccines as well as pass...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Immunol Immunother
Main Authors: Muthumani, Kar, Marnin, Liron, Kudchodkar, Sagar B., Perales-Puchalt, Alfredo, Choi, Hyeree, Agarwal, Sangya, Scott, Veronica L., Reuschel, Emma L., Zaidi, Faraz I., Duperret, Elizabeth K., Wise, Megan C., Kraynyak, Kimberly A., Ugen, Kenneth. E., Sardesai, Niranjan Y., Joseph Kim, J., Weiner, David B.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5676807/
https://ncbi.nlm.nih.gov/pubmed/28819703
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-017-2042-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados